Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Carbidopa + Levodopa
- Therapeutic area
- CNS & mental health
- Drug class
- Antiparkinson medicines
- ATC
- N04BA
- Strength
- 250 mg + 25 mg
- Dosage form
- Tablet
- Pack
- 10x10
- Registration no.
- 060545
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-26 02:57
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 1,407.73 to 1,477.27 (+4.9%) between 13 Jan 2026 and 25 Sep 2026 · 2 official price records · pack 10x10
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Aptidopa 250 mg + 25 mg, 10x10: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/aptidopa-250-mg-25-mg-060545-10x10-aptcure-pvt-ltd/ (accessed 27 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,477.27 | 2026-09-25 | 2026-09-26 | DRAP PharmaPrice Index (refreshed from snapshot #88) | Current |
| PKR 1,407.73 | 2026-01-13 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 060545Price and registration data on this page were observed on 26 September 2026. Records change over time, so please cite the observation date alongside the access date.
